Classical gene amplifications in human breast cancer are not associated with distant solid metastases
1997

Gene Amplifications in Breast Cancer Metastases

Sample size: 184 publication Evidence: moderate

Author Information

Author(s): K Driouch, MH Champeme, M Beuzelin, I Biechel, R Lidereau

Primary Institution: Centre Rene Huguenin

Hypothesis

Are gene amplifications associated with the progression of breast cancer to distant metastases?

Conclusion

The study found that gene amplifications of MYC and ERBB2 are primarily involved in the genesis of primary breast tumors rather than in the progression to distant metastases.

Supporting Evidence

  • Gene amplifications were significantly lower in distant metastases compared to primary tumors for the MYC gene.
  • Only 11% of solid metastases showed amplifications on at least one of the four genes tested.
  • The frequency of amplification of the 11q13 band was similar in primary tumors and metastases.

Takeaway

This study looked at breast cancer and found that certain genes are important for the original tumor but not for spreading to other parts of the body.

Methodology

The study used restriction fragment length polymorphism (RFLP) analysis to screen 62 distant metastases and 122 primary breast tumors for gene amplifications.

Potential Biases

The patients underwent non-randomized treatments, which may introduce bias.

Limitations

The study did not include local recurrences and focused only on distant metastases.

Participant Demographics

The study included 122 patients with primary breast tumors and 62 patients with distant metastases, primarily invasive tumors.

Statistical Information

P-Value

< 0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication